<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">nefr-138</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ. КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES. CLINICAL INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>ДИНАМИКА БИОМАРКЕРОВ ПОВРЕЖДЕНИЯ ПОЧЕК ПОСЛЕ ТРАНСПЛАНТАЦИИ ГЕМОПОЭТИЧЕСКИХ СТВОЛОВЫХ КЛЕТОК (ПИЛОТНОЕ ИССЛЕДОВАНИЕ)</article-title><trans-title-group xml:lang="en"><trans-title>DYNAMICS OF KIDNEY INJURY BIOMARKERS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION (PILOT STUDY)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смирнов</surname><given-names>К. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Smirnov</surname><given-names>K. A.</given-names></name></name-alternatives><email xlink:type="simple">smimoff2610@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Добронравов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Dobronravov</surname><given-names>V. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Афанасьев</surname><given-names>Б. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Afanasiev</surname><given-names>B. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Галкина</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Galkina</surname><given-names>O. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зубина</surname><given-names>И. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Zubina</surname><given-names>I. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Богданова</surname><given-names>Е. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Bogdanova</surname><given-names>E. O.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Блинова</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Blinova</surname><given-names>T. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бархатов</surname><given-names>И. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Barhatov</surname><given-names>I. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смирнов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Smirnov</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П.Павлова; Научно-исследовательский институт нефрологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Nephrology Research Institute, Pavlov First Saint-Petersburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Научно-исследовательский институт детской онкологии, гематологии и трансплантологии им. Р.М. Горбачёвой</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Raisa Gorbacheva Memorial Research Institute for Pediatric Oncology, Hematology and Transplantation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Научно-исследовательский институт нефрологии Первого Санкт-Петербургского государственного медицинского университета им. акад. И.П.Павлова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Nephrology Research Institute, Pavlov First Saint-Petersburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Научно-исследовательский институт нефрологии Первого Санкт-Петербургского государственного медицинского университета им.акад.И.П.Павлова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Nephrology Research Institute, Pavlov First Saint-Petersburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>01</day><month>11</month><year>2015</year></pub-date><volume>19</volume><issue>6</issue><fpage>28</fpage><lpage>33</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Смирнов К.А., Добронравов В.А., Афанасьев Б.В., Галкина О.В., Зубина И.М., Богданова Е.О., Блинова Т.В., Бархатов И.М., Смирнов А.В., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Смирнов К.А., Добронравов В.А., Афанасьев Б.В., Галкина О.В., Зубина И.М., Богданова Е.О., Блинова Т.В., Бархатов И.М., Смирнов А.В.</copyright-holder><copyright-holder xml:lang="en">Smirnov K.A., Dobronravov V.A., Afanasiev B.V., Galkina O.V., Zubina I.M., Bogdanova E.O., Blinova T.V., Barhatov I.M., Smirnov A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/138">https://journal.nephrolog.ru/jour/article/view/138</self-uri><abstract><p>ЦЕЛЬ ИССЛЕДОВАНИЯ: оценка динамики биомаркеров тубулярного повреждения (БМ) и частоты развития острого повреждения почек (ОПП) по данным рутинной диагностики после трансплантации гемопоэтических стволовых клеток (ТГСК). ПАЦИЕНТЫ И МЕТОДЫ. Обследовано 30 пациентов после аллогенной ТГСК. В образцах мочи за 7 дней до ТГСК (неделя 0), на неделях 1-4 после ТГСК измерены концентрации БМ (кальбиндин, кластерин, интерлейкин-18, IL-18), молекула повреждения почек-1 (KIM-1), глутатион-S-трансфераза (p-класс) (GST-п), протеин хемотаксиса моноцитов-1 (MCP-1). В указанные временные периоды определён креатинин (Cr). Клиническое ОПП диагностировали согласно классификациям AKIN/KDIGO. РЕЗУЛЬТАТЫ. Диагностика ОПП(AKIN/KDIGO): доля случаев с ОПП(AKIN/KDIGO) в 1-ю и 2-ю недели после ТГСК - 7%, на 3-й неделе -17%, на 4-й неделе - 54% (р&lt;0,05). Частота выявления случаев повышения концентраций 1 и более БМ на неделе 1 после ТГСК составила 78%, на неделе 2 - 85%, на неделе 3 - 90%. Доля случаев одновременного повышения концентраций 4 и более БМ после ТГСК прогрессивно увеличивалась: 6% - до ТГСК и 38% - на неделе 4 после ТГСК. К 4-й неделе только в 6% случаев не было зарегистрировано повышение БМ, а кумулятивная доля случаев без клинических критериев ОПП(AKIN/KDIGO) была значительно больше и составила 40%. Частота развития ОПП(AKIN/KDIGO) возрастала при увеличении числа одновременно повышенных БМ. Выявлены достоверные прямые связи между БМ проксимальных канальцев; дистальных канальцев, а также между БМ, характеризующими как проксимальное, так и дистальное повреждение. ROC-анализ показал, что число БМ обладает достаточной чувствительностью в отношении прогноза развития ОПП (AKIN/KDIGO) (SAUC=0,69, р=0,006). ЗАКЛЮЧЕНИЕ. Повышение концентраций БМ, указывающих на повреждение канальцев, после ТГСК выявляется у большинства пациентов (90%) и предшествует развитию клинического ОПП (AKIN/KDIGO). БМ могут быть использованы для оценки субклинического структурного тубулярного повреждения и прогнозирования развития глобальной дисфункции органа - ОПП.</p></abstract><trans-abstract xml:lang="en"><p>THE AIM. To evaluate dynamics of tubular damage biomarkers (BMs) and to determine frequency of acute kidney injury (AKI) according to routine diagnostics following hematopoietic stem cell transplantation (HSCT). PATIENTS AND METHODS. The study involved 30 patients after allogeneic hematopoietic stem cell transplantation (HSCT). The urine samples were taken 7 days prior to HSCT (week 0), on the weeks 1, 2, 3 and 4. BMs concentrations (calbindin, clusterin, IL-18, KIM-1, GST-п, MCP-1) were estimated. Serum creatinine was measured at the same time periods. Clinical AKI was diagnosed according to AKIN/ KDIGO (acute kidney injury network/kidney disease improving global outcomes) classification systems. RESULTS. Clinical AKI (AKIN/KDIGO) diagnostics: the proportion of AKI (AKШN/KDIGO) cases on the weeks 1 and 2 after HSCT was 7%, on the week 3 - 17%, on the week 4- 54% (p &lt;0.05). The frequency of cases with increase of 1 and more BMs concentrations on the week 1 following HSCT was 78%, on the week 2 - 85% and thereafter on the week 3 - 90%. The proportion of cases with simultaneous elevation of 4 and more BMs after HSCT had been progressively increasing: from 6% before HSCT to 38% on the week 4 after it. By week 4 only in 6% of cases no increase in BMs concentration was found, while the cumulative proportion of cases without clinical AKI criteria (AKIN/KDIGO) was much more higher and reached 40%. The frequency of AKI (AkIN/KDIGO) development increased in relation to the number of simultaneously increased BMs. Statistically significant direct correlations were found between BMs of proximal and distal tubules, as well as between BMs simultaneously showing the damage of both proximal and distal tubule. ROC analysis showed that BMs number has sufficient sensitivity in terms of prognosis of clinical AKI (AKIN/KDIGO) development (SAUC=0,69; p=0.006). CONCLUSION. The BMs concentration increase, showing the tubular damage following HSCT, was found in majority of patients (90%) and preceded the development of clinical AKI (AKIN/KDIGO). The evaluation of BMs concentration may be used for the assessment of subclinical tubular structural damage and prognosis of AKI.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>острое повреждение почек</kwd><kwd>трансплантация гемопоэтических стволовых клеток</kwd><kwd>биомаркеры острого повреждения почек</kwd></kwd-group><kwd-group xml:lang="en"><kwd>acute kidney injury</kwd><kwd>hematopoietic stem cell transplantation</kwd><kwd>acute kidney injury biomarkers</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Chertow G.M, Burdick E, Honour M. et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16(11): 3365-3370</mixed-citation><mixed-citation xml:lang="en">Chertow G.M, Burdick E, Honour M. et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16(11): 3365-3370</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Wang H.E, Muntner P, Chertow G.M. et al. Acute kidney injury and mortality in hospitalized patients. Am J Nephrol 2012; 35(4): 349-355</mixed-citation><mixed-citation xml:lang="en">Wang H.E, Muntner P, Chertow G.M. et al. Acute kidney injury and mortality in hospitalized patients. Am J Nephrol 2012; 35(4): 349-355</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Uchino S, Bellomo R, Goldsmith D. et al. An assesment of the RIFLE criteria for acute kidney failure in hospitalized patients. Crit Care Med 2006; 34(7): 1913-1917</mixed-citation><mixed-citation xml:lang="en">Uchino S, Bellomo R, Goldsmith D. et al. An assesment of the RIFLE criteria for acute kidney failure in hospitalized patients. Crit Care Med 2006; 34(7): 1913-1917</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Mandelbaum T, Scott D.J, Lee J. et al. Outcome of critically ill patients with acute kidney injury using the Acute kidney injury network criteria. Crit Care Med 2011; 39(12): 2659-2664</mixed-citation><mixed-citation xml:lang="en">Mandelbaum T, Scott D.J, Lee J. et al. Outcome of critically ill patients with acute kidney injury using the Acute kidney injury network criteria. Crit Care Med 2011; 39(12): 2659-2664</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Nin N, Lombardi R, Frutos-Vivar F et al. VENTILA Group: Early and small changes in serum creatinine concentrations are associated with mortality in mechanically ventilated patients. Shock 2010; 34(2): 109-116</mixed-citation><mixed-citation xml:lang="en">Nin N, Lombardi R, Frutos-Vivar F et al. VENTILA Group: Early and small changes in serum creatinine concentrations are associated with mortality in mechanically ventilated patients. Shock 2010; 34(2): 109-116</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Zeng X, Mcmahon G.M, Brunelli S.M. et al. Incidence, Outcomes, and Comparisons across Definitions of AKI in Hospitalized Individuals. Clin J Am Soc Nephrol 2014;9(1): 12-20</mixed-citation><mixed-citation xml:lang="en">Zeng X, Mcmahon G.M, Brunelli S.M. et al. Incidence, Outcomes, and Comparisons across Definitions of AKI in Hospitalized Individuals. Clin J Am Soc Nephrol 2014;9(1): 12-20</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hahn T, Rondeau C, Shaukat A. et al. Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients. Bone Marrow Transplant 2003; 32(4): 405-410</mixed-citation><mixed-citation xml:lang="en">Hahn T, Rondeau C, Shaukat A. et al. Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients. Bone Marrow Transplant 2003; 32(4): 405-410</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Bucaloiu I.D, Kirchner H.L, Norfolk E.R. et al. Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int 2012;81(5): 477-485</mixed-citation><mixed-citation xml:lang="en">Bucaloiu I.D, Kirchner H.L, Norfolk E.R. et al. Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int 2012;81(5): 477-485</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Wu V.C, Huang T.M, Lai C.F. et al. Acute on chronic kidney injury at hospital discharge is associated with long-term dialysis and mortality. Kidney Int 2011;80(11): 1222-1230</mixed-citation><mixed-citation xml:lang="en">Wu V.C, Huang T.M, Lai C.F. et al. Acute on chronic kidney injury at hospital discharge is associated with long-term dialysis and mortality. Kidney Int 2011;80(11): 1222-1230</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Chawla L.S, Amdur R.L, Amodeo S. et al. The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int 2011;79(12): 1361-1369</mixed-citation><mixed-citation xml:lang="en">Chawla L.S, Amdur R.L, Amodeo S. et al. The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int 2011;79(12): 1361-1369</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Lafrance J.P, Djurdjev O, Levin A. Incidence and outcomes of acute kidney injury in a referred chronic kidney disease cohort. Nephrol Dial Transplant 2010;25(7): 2203-2209</mixed-citation><mixed-citation xml:lang="en">Lafrance J.P, Djurdjev O, Levin A. Incidence and outcomes of acute kidney injury in a referred chronic kidney disease cohort. Nephrol Dial Transplant 2010;25(7): 2203-2209</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lopes J.A, Jorge S. Acute kidney injury following HCT: incidence, risk factors and outcome. Bone Marrow transplantation 2011;46(11): 1399-1408</mixed-citation><mixed-citation xml:lang="en">Lopes J.A, Jorge S. Acute kidney injury following HCT: incidence, risk factors and outcome. Bone Marrow transplantation 2011;46(11): 1399-1408</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss A.S, Sandmaier B.M, Storer B. et al. Chronic kidney disease following non-myeloablative hematopoietic cell transplantation. Am J Transplant 2006;6(1): 89-94</mixed-citation><mixed-citation xml:lang="en">Weiss A.S, Sandmaier B.M, Storer B. et al. Chronic kidney disease following non-myeloablative hematopoietic cell transplantation. Am J Transplant 2006;6(1): 89-94</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ellis M.J, Parikh C.R, Inriq J.K. et al. Chronic kidney disease after hematopoietic cell transplantation: a systematic review. Am J Transplant 2008;8(11): 2378-2390</mixed-citation><mixed-citation xml:lang="en">Ellis M.J, Parikh C.R, Inriq J.K. et al. Chronic kidney disease after hematopoietic cell transplantation: a systematic review. Am J Transplant 2008;8(11): 2378-2390</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kogon A, Hingorani S. Acute kidney injury in hematopoietic cell transplantation. Semin Nephrol 2010;30(6): 615-626</mixed-citation><mixed-citation xml:lang="en">Kogon A, Hingorani S. Acute kidney injury in hematopoietic cell transplantation. Semin Nephrol 2010;30(6): 615-626</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Bellomo R, Kellum J.A, Ronco C. Defining acute renal failure: physiological principles. Intensive Care Med 2004;30(1): 33-37</mixed-citation><mixed-citation xml:lang="en">Bellomo R, Kellum J.A, Ronco C. Defining acute renal failure: physiological principles. Intensive Care Med 2004;30(1): 33-37</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Coca S.G, Parikh C.R. Urinary biomarkers for acute kidney injury: perspectives on translation. Clin J Am Soc Nephrol 2008;3(2): 481-490</mixed-citation><mixed-citation xml:lang="en">Coca S.G, Parikh C.R. Urinary biomarkers for acute kidney injury: perspectives on translation. Clin J Am Soc Nephrol 2008;3(2): 481-490</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Moore E, Bellomo R. Novel biomarkers of acute kidney injury: ready for clinical application? Curr Opin Crit Care 2010;16(6): 523-525</mixed-citation><mixed-citation xml:lang="en">Moore E, Bellomo R. Novel biomarkers of acute kidney injury: ready for clinical application? Curr Opin Crit Care 2010;16(6): 523-525</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Nguyen M.T, Devarajan P Biomarkers for the early detection of acute kidney injury 2008;23(12): 2151-2157</mixed-citation><mixed-citation xml:lang="en">Nguyen M.T, Devarajan P Biomarkers for the early detection of acute kidney injury 2008;23(12): 2151-2157</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Doi K, Yuen P.S, Eisner C. Reduced production of creatinine limits its use as marker of kidney injury in sepsis. J Am Soc Nephrol 2009;20(6): 1217-1221</mixed-citation><mixed-citation xml:lang="en">Doi K, Yuen P.S, Eisner C. Reduced production of creatinine limits its use as marker of kidney injury in sepsis. J Am Soc Nephrol 2009;20(6): 1217-1221</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Soni S.S, Cruz D, Bobek I. NGAL: a biomarker of acute kidney injury and other systemic conditions. Int Urol Nephrol 2010; 42(1): 141-150</mixed-citation><mixed-citation xml:lang="en">Soni S.S, Cruz D, Bobek I. NGAL: a biomarker of acute kidney injury and other systemic conditions. Int Urol Nephrol 2010; 42(1): 141-150</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ghatanatti R, Teli A, Tirkey S.S. et al. Role of renal biomarkers as predictors of acute kidney injury in cardiac surgery. Asian Cardiovasc Thorac Ann 2014;22(2): 234-241</mixed-citation><mixed-citation xml:lang="en">Ghatanatti R, Teli A, Tirkey S.S. et al. Role of renal biomarkers as predictors of acute kidney injury in cardiac surgery. Asian Cardiovasc Thorac Ann 2014;22(2): 234-241</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Добронравов В.А. Обзор патофизиологии острого повреждения почек. В: Смирнов А.В, Добронравов В.А, Румянцев А.Ш, Каюков И.Г. Острое повреждение почек. МИА, 2015, 3076</mixed-citation><mixed-citation xml:lang="en">Добронравов В.А. Обзор патофизиологии острого повреждения почек. В: Смирнов А.В, Добронравов В.А, Румянцев А.Ш, Каюков И.Г. Острое повреждение почек. МИА, 2015, 3076</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Field M, Dronovalli V, Mistry P. et al. Urinary biomarkers of acute kidney injury in diceased organ donors-kidney injury molecule-1 as an adjunct to predicting outcome. Clin Transplant 2014;28(7): 808-815</mixed-citation><mixed-citation xml:lang="en">Field M, Dronovalli V, Mistry P. et al. Urinary biomarkers of acute kidney injury in diceased organ donors-kidney injury molecule-1 as an adjunct to predicting outcome. Clin Transplant 2014;28(7): 808-815</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Han W.K, Wagener G, Zhu Y. at al. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol 2009 4(5): 873-882</mixed-citation><mixed-citation xml:lang="en">Han W.K, Wagener G, Zhu Y. at al. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol 2009 4(5): 873-882</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Levi T.M, de Souza S.P, de Magalhaes J.G. et al. Comparison of the RIFLE, AKIN and KDIGO criteria to predict mortality in critically ill patients. Rev Bras Ter Intensiva 2013;25(4): 290-296</mixed-citation><mixed-citation xml:lang="en">Levi T.M, de Souza S.P, de Magalhaes J.G. et al. Comparison of the RIFLE, AKIN and KDIGO criteria to predict mortality in critically ill patients. Rev Bras Ter Intensiva 2013;25(4): 290-296</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
